UAE Medical Device Manufacturer: MOHAP + ESMA Guide 2026

Updated August 2026. Launching a medical device manufacturing company in the UAE positions your business in one of the Gulf’s most dynamic and fastest-growing healthcare technology sectors. The UAE medical device market reached AED 7.3 billion (USD 2 billion) in 2025, supported by a healthcare infrastructure spending budget of AED 73 billion through 2026 under the UAE Health Strategy 2031. This guide walks through every regulatory requirement—from MOHAP medical device registration to ESMA product conformity—along with facility investment benchmarks and the optimal free zone strategy for Class I, II, and III device manufacturers.

UAE Medical Device Market: Opportunity and Growth Drivers 2026

The UAE medical device sector encompasses diagnostic equipment, surgical instruments, implantable devices, imaging systems, point-of-care diagnostics, and connected health monitors. With 14 JCI-accredited hospitals, 120+ private hospitals, and a government healthcare capital expenditure exceeding AED 20 billion annually, demand for locally manufactured and distributed medical devices continues to accelerate. The UAE serves as the primary distribution and value-added manufacturing hub for the GCC medical device market, which totalled USD 3.8 billion in 2025.

Government procurement preferences under the UAE In-Country Value (ICV) program and DHA vendor registration requirements increasingly favour locally manufactured devices. Medical device manufacturers registered with MOHAP and holding UAE Conformity Assessment Scheme (ECAS) certificates issued by ESMA are eligible for ICV score enhancements of 3–8 percentage points in government tenders.

Investors reviewing UAE company formation requirements for medical devices should note that mainland companies can engage in government hospital tenders directly, while free zone companies typically require a local distributor arrangement for domestic sales—a structural consideration that significantly affects commercial model design.

MOHAP Medical Device Registration: Regulatory Framework

UAE medical device regulation is governed by Cabinet Resolution No. 66 of 2023, which replaced the earlier 2020 framework with a harmonised system aligned with the Global Medical Device Nomenclature (GMDN) and the International Medical Device Regulators Forum (IMDRF) guidelines. MOHAP’s Medical Devices Department administers device registration through the UAE Medical Device National Registration System (MDNS), accessible at mohap.gov.ae.

The MOHAP registration process requires: (1) appointment of a UAE Authorized Representative (Wakeel) who must be a MOHAP-licensed medical device trader; (2) submission of a Technical Documentation File (TDF) including device description, intended use, risk management report (ISO 14971), clinical evidence, labelling, and IFU in Arabic and English; (3) conformity assessment evidence (CE marking, FDA 510(k), or MDSAP certificate accepted as primary evidence); (4) ESMA product conformity certificate where applicable; and (5) facility inspection for Class III devices and certain Class IIb products.

Registration fees under the 2023 framework: Class I devices AED 1,000–3,000; Class IIa AED 3,000–8,000; Class IIb AED 8,000–15,000; Class III AED 15,000–30,000. Registrations are valid for 5 years with no change of ownership procedures. The UAE also participates in the AHWP (Asian Harmonization Working Party) and maintains unilateral recognition of CE marking as primary conformity evidence since 2022.

ESMA Product Conformity Assessment for Medical Devices

The Emirates Authority for Standardization and Metrology (ESMA) enforces the UAE Conformity Assurance Scheme (ECAS) for medical devices that fall within the scope of UAE.S GSO technical standards. ESMA certification is required for electrically powered medical devices, devices with radio frequency components, and devices subject to electromagnetic compatibility (EMC) requirements under UAE.S GSO IEC 60601 series standards.

The ECAS certification process for medical devices involves: product sample testing at an ESMA-accredited laboratory (or at an overseas accredited lab with test report recognition), factory audit (for Class B and C product risk levels under ECAS), and certificate issuance valid for 3 years. ESMA-accredited laboratories in the UAE include TÜV Rheinland UAE, SGS UAE, and Bureau Veritas Dubai.

ESMA certification is coordinated with GCC Standardization Organization (GSO) for mutual recognition across Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and UAE—enabling a single ECAS certificate to unlock distribution across the GCC market. For manufacturers reviewing the UAE free zone comparison for medical devices, proximity to ESMA-accredited labs and MOHAP offices in Dubai or Abu Dhabi is a practical consideration.

Device Classification System: Class I, II, and III in the UAE

UAE medical device classification follows a four-class system (Class I, IIa, IIb, III) based on intended use, body contact duration, invasiveness, and energy source, aligned with EU MDR 2017/745 classification rules.

Class	Risk Level	Examples	MOHAP Review Time	Required Evidence
Class I	Low	Bandages, tongue depressors, non-sterile gloves	3–6 months	Declaration of Conformity
Class IIa	Medium-Low	Hearing aids, contact lens solutions, infusion pumps	6–12 months	CE/FDA + Technical File
Class IIb	Medium-High	Ventilators, surgical lasers, dialysis equipment	12–18 months	CE/FDA + Clinical Data
Class III	High	Cardiac stents, implantable pacemakers, spinal implants	18–36 months	CE/FDA + PMS + Clinical Trials

Manufacturing Facility Requirements and Location Strategy

Medical device manufacturing in the UAE requires a licensed manufacturing facility meeting ISO 13485:2016 (Medical Devices Quality Management System) requirements as a minimum. Cleanroom requirements depend on device category: Class I non-sterile devices can be assembled in ISO 8 (Class 100,000) environments; sterile devices require ISO 7 (Class 10,000) or ISO 5 (Class 100) terminal sterilisation rooms.

Leading free zone locations for medical device manufacturing include: Jebel Ali Free Zone (JAFZA) for volume manufacturing and distribution, with 60+ medical device companies including Fresenius Medical Care and Cardinal Health; Dubai Healthcare City (DHCC) for manufacturing companies requiring proximity to a hospital cluster and clinical validation environment; Abu Dhabi Global Market (ADGM) for holding company structures managing IP and licensing arrangements.

Mainland Dubai (DED) and Abu Dhabi (ADDED) company structures are preferred for manufacturers targeting direct government hospital and clinic supply contracts, which represent approximately 40% of UAE medical device demand. For UAE private medical clinic operators interested in in-house device production, a separate manufacturing entity is required under MOHAP licensing frameworks.

Capital Investment Breakdown: AED 5M–200M

Medical device manufacturing facility investment in the UAE varies significantly by device class and production technology. For Class I assembly operations (e.g., disposable surgical instruments, diagnostic kits), a 500–1,000 sqm ISO 8 assembly facility with basic cleanroom systems costs AED 5M–15M, making it the most accessible entry point for UAE medical device manufacturing.

Class IIa and IIb manufacturing—covering electronics-based diagnostics, orthopaedic implants, and active therapeutic devices—requires ISO 7 cleanroom construction (AED 6,000–10,000/sqm), specialized CNC machining or injection moulding equipment (AED 8M–25M), and electronic assembly and testing stations. Total investment for a mid-scale Class IIa/IIb facility runs AED 30M–80M.

Class III implantable device manufacturing represents the highest investment tier at AED 80M–200M, requiring precision manufacturing under ISO 5 conditions, extensive biocompatibility testing infrastructure, sterilisation validation (EtO, gamma, or e-beam), and a comprehensive post-market surveillance (PMS) system. Investors considering the UAE corporate tax free zone qualification for medical device manufacturing should note that qualifying income from manufacturing and export activities in designated free zones is taxed at 0% under UAE CT Law Federal Decree-Law No. 47 of 2022.

Quality Management and Post-Market Surveillance Requirements

UAE medical device manufacturers must maintain an ISO 13485:2016-certified Quality Management System, with annual surveillance audits by an accredited certification body. Post-market surveillance (PMS) requirements under Cabinet Resolution No. 66 of 2023 mandate: a serious adverse event (SAE) reporting system with 72-hour notification to MOHAP for life-threatening events; periodic safety update reports (PSUR) at 12-month intervals for Class IIb and III devices; field safety corrective actions (FSCA) management; and a vigilance system capable of issuing safety alerts across UAE distribution channels within 24 hours.

The UAE free zone comparison for medical device QMS compliance should factor in access to ISO 13485 certification bodies: TÜV SÜD, BSI Group, and SGS all maintain UAE offices and can conduct local certification audits, eliminating the need for international audit travel and reducing QMS certification timelines to 4–8 months for well-prepared facilities.

What licenses are required to manufacture medical devices in the UAE?

UAE medical device manufacturers require: (1) a trade license from the relevant mainland department of economic development or free zone authority; (2) MOHAP medical device registration for each product manufactured; (3) ESMA ECAS certificate for electrically powered and RF-enabled devices; and (4) ISO 13485:2016 QMS certification. Facilities manufacturing sterile devices additionally require MOHAP GMP inspection and sterilization validation approval.

Is CE marking accepted for UAE medical device registration?

Yes. CE marking issued by a recognised EU Notified Body is accepted by MOHAP as primary conformity evidence for Class IIa, IIb, and III devices since UAE Cabinet Resolution No. 66 of 2023. For Class I devices, a manufacturer’s Declaration of Conformity is sufficient. FDA 510(k) clearance and Canadian MDEL are also accepted as equivalent evidence under MOHAP’s international harmonisation policy.

How long does MOHAP medical device registration take in the UAE?

MOHAP registration timelines depend on device class: Class I devices take 3–6 months with complete documentation; Class IIa takes 6–12 months; Class IIb 12–18 months; and Class III 18–36 months. Incomplete dossiers are a common cause of delays—engaging a UAE regulatory consultant with direct MOHAP liaison experience can reduce registration timelines by 30–50%.

Do medical device manufacturers need to be based in the UAE or can they register through a distributor?

Foreign medical device manufacturers can register products in the UAE through a MOHAP-licensed UAE Authorized Representative (distributor or agent) without establishing a local manufacturing or office presence. However, UAE-based manufacturing companies receive preference in government procurement under the In-Country Value (ICV) program and can engage in direct tenders, which increases commercial margins by 15–25% versus third-party distribution arrangements.

What is the corporate tax treatment for medical device manufacturing in UAE free zones?

Medical device manufacturing companies established in designated UAE free zones and earning qualifying income from manufacturing and export activities are subject to 0% corporate tax under UAE Federal Decree-Law No. 47 of 2022. Income from domestic UAE sales (outside the free zone) is taxed at 9% above the AED 375,000 threshold. Free zone companies must maintain substance requirements—including maintaining adequate employees, premises, and management in the UAE—to qualify for the 0% rate.